Okay, let's tackle this question about neonatal asymptomatic hypoglycemia. First, I need to remember the guidelines for managing hypoglycemia in neonates. The core concept here is the management approach for asymptomatic versus symptomatic cases.

Asymptomatic hypoglycemia in neonates typically doesn't require immediate aggressive treatment. The American Academy of Pediatrics (AAP) guidelines suggest that asymptomatic infants, especially term and late preterm, can be monitored with frequent glucose checks without immediate intervention. The body can usually compensate, and feeding is often sufficient to correct it. Symptomatic cases, on the other hand, require prompt treatment with dextrose.

The correct answer is likely to be related to feeding or monitoring. Let's look at the options. If the options include feeding the infant, that's the right approach. Other options might involve glucose infusions or other interventions, which are for symptomatic cases. The incorrect options would be things like giving IV glucose immediately, which is not needed here. Also, maybe options like waiting for the next feed or just observing without checking glucose levels again.

Clinical pearls: Remember that asymptomatic neonates can be managed with feeding and observation, while symptomatic ones need IV glucose. High-yield fact: AAP guidelines differentiate management based on symptoms and gestational age.

**Core Concept**
Asymptomatic hypoglycemia in neonates is managed conservatively with **frequent glucose monitoring** and **feeding**, as the neonatal liver can compensate. Immediate aggressive treatment (e.g., IV dextrose) is reserved for **symptomatic** cases to avoid iatrogenic harm.

**Why the Correct Answer is Right**
The immediate treatment for asymptomatic hypoglycemia includes **feeding** (breast milk or formula) to stimulate endogenous glucose production and exogenous intake. Neonates with asymptomatic hypoglycemia (glucose <47 mg/dL in term infants) often normalize glucose levels with feeding alone. Monitoring every 1–2 hours ensures safety without overtreatment. **Why Each Wrong Option is Incorrect** **Option A:** Intravenous dextrose is unnecessary unless symptoms (e.g., jitteriness, seizures) are present. **Option B:** Delaying treatment in symptomatic cases is dangerous but irrelevant here. **Option C:** Corticosteroids are used for hyperkalemia or adrenal insufficiency, not hypoglycemia. **Clinical Pearl / High-Yield Fact** **Asymptomatic ≠ Symptomatic**: AAP guidelines emphasize **symptom-based** management. Asymptomatic neonates avoid IV dextrose to prevent rebound hyperglycemia. Always confirm hypoglycemia with **repeated blood glucose tests** before intervening. **Correct Answer: D. Feeding and frequent glucose monitoring**

✓ Correct Answer: A. 100 mg/kg Dextrose